Growth factors and growth factor gene therapies for treating chronic wounds

Area of Science:

• Regenerative Medicine
• Wound Healing Biology
• Biotechnology

Background:

• Chronic wounds represent a significant global health challenge with inadequate current treatments.
• Dysregulated growth factor signaling is a key factor in non-healing chronic wounds.
• Existing therapies, including protein growth factors and gene therapy, face limitations in stability, efficacy, and safety.

Purpose of the Study:

• To review the current landscape of chronic wound healing.
• To explore the potential of growth factor therapies for chronic wounds.
• To discuss advancements in single and multi-growth factor approaches, including cell-based and gene therapy.

Main Methods:

• Literature review of chronic wound healing mechanisms.
• Analysis of current standards of care and their limitations.
• Examination of recent research in growth factor, cell-based, and gene therapy for wound healing.

Main Results:

• Current chronic wound treatments often fail to achieve complete closure or prevent recurrence.
• Protein-based growth factors have shown promise but suffer from instability and off-target effects.
• Gene therapy presents an alternative but faces safety and delivery efficacy challenges.
• Multi-growth factor strategies demonstrate enhanced efficacy in preclinical studies compared to single-factor approaches.

Conclusions:

• Growth factor therapies, particularly multi-growth factor approaches, hold significant potential for advancing chronic wound treatment.
• Addressing growth factor deficiencies is crucial for promoting effective wound healing.
• Future research should focus on optimizing delivery and safety of multi-growth factor therapeutics for clinical translation.